PJ-150021

N/A

Report date: 2022/01/10 10:59:51
NME

Base Information

Drug NamePJ-150021
Drug Alias NamePJ-150021
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKunshan Pengji Kaifeng Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKunshan Pengji Kaifeng Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A